Immune Globulin (Human) 10% (Gamunex-C) PEG Process (IVIG-PEG)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Immune Globulin (Human) 10% (Gamunex-C) PEG Process (IVIG-PEG), covering 2023-06-05 to 2023-06-05. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Immune Globulin (Human) 10% (Gamunex-C) PEG Process (IVIG-PEG) Compared to Gamunex-C in Participants With Primary Humoral Immunodeficiency [Phase 3]